Quick Asked: Werewolf Therapeutics Contact Us?
Last update: 25 Apr, 2024 
233 Views
Listing Results Werewolf Therapeutics Contact Us? Question Answers
Timothy Trost Chief Finan.. Werewolf Therapeutics
View Timothy Trost's business profile as Chief Financial Officer at Werewolf Therapeutics. Find contact's direct phone number, email address, work history, and more.
Werewolf moves into MPM’s web of immunotherapy startups STAT
Alex Hogan/STAT. C AMBRIDGE, Mass. — No one seems to quite know who gave Werewolf Therapeutics its name. But it’s very clear where the new startup, founded in 2017 by MPM Capital, got its lab
David Cordo Chief Financi.. Werewolf Therapeutics
View David Cordo's business profile as Chief Financial Officer at Werewolf Therapeutics. Find contact's direct phone number, email address, work history, and more.
Join Us Werewolf Therapeutics Inc.
We’re looking for vibrant, creative, forward-thinking people to join our team. Explore our open positions below and let us know that you’re interested. We’d love to talk to you. Submit a cover letter and resume/CV to [email protected]. We are currently seeking a Staff Accountant to join our rapidly growing team. Full Job Description.
Werewolf Therapeutics to Present at Upcoming NextGen
Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer.
Lab Team Anandasabapathy Lab
Komal Pradhan- Associate Scientist II at Pandion Therapeutics. Immunology at Werewolf Therapeutics. Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Contact Us. Weill Cornell Medicine Anandasabapathy Lab 413 E 69th St., Rm 920 New York, NY 10021 Phone:
HOWL Werewolf Therapeutics Inc. Profile MarketWatch
607 952-0555 Werewolf Therapeutics Inc. 1030 Massachusetts Avenue. Suite 210. Cambridge, Massachusetts 02138. Phone 1 607 952-0555. Industry Biotechnology. Sector ...
Chimerix Inc (CMRXQ) Quote Press Release The Globe
301.332.5574 VERGE Scientific Communications. 301.332.5574. [email protected]. Company Contact: Ellen Lubman. Chief Business Officer. Werewolf Therapeutics. [email protected]. A photo
Iovance Biotherapeutics Contact
650-260-7120 Contact. Iovance Biotherapeutics Contact. Our Locations. Headquarters (San Carlos, CA) 999 Skyway Road, Suite 150 San Carlos, CA 94070 Phone: 650-260-7120 Research Facility (Tampa, FL) 3802 Spectrum Blvd. Suite 206 Tampa, FL 33612 Phone: 813-369-5999 Corporate Office (Philadelphia, PA) One Crescent Drive, Suite 303
Werewolf Therapeutics Company Profile: Stock ...
+1 (617) 000-0000 Contact Information Website www.werewolftx.com Ownership Status Publicly Held Financing Status Formerly VC-backed Primary Industry Drug Discovery Other Industries Biotechnology Drug Delivery Stock Exchange NAS Primary Office 1030 Massachusetts Avenue Suite 210 Cambridge, MA 02138 United States +1 (617) 000-0000 Werewolf Therapeutics Timeline
Contact Us Grey Wolf Therapeutics
Contact Us. If you have a media, investment or collaboration enquiry, you can get in touch by phone or via the contact form below. Job Vacancies. We do not currently have any positions available. * I consent to giving the above information to Grey Wolf Therapeutics for the purpose of receiving information about my enquiry.
Contact Us Werewolf Therapeutics Inc.
Contact us for information about media, investors, employment opportunities regarding Werewolf Therapeutics.
Werewolf Therapeutics, Inc. (HOWL) Company Profile
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, with the help of its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of
Werewolf Therapeutics to Present Data on its INDUKINE
Posters Detail Preclinical Data on the Company’s WTX-124 and WTX-330 Molecules for the Potential Treatment of CancerCAMBRIDGE, Mass., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc
Werewolf Therapeutics LinkedIn
Werewolf Therapeutics. 2,737 followers. 1mo. Report this post. In honor of Childhood Cancer Awareness Month, the wolf pack huddled to create handmade #cards for Cardz for Kidz, a Chicago-based
Home Page Werewolf Therapeutics Inc.
Werewolf Therapeutics is a highly innovative company striving to redefine the cancer treatment landscape with potential best-in-class therapies. We are advancing a novel class of cancer biotherapeutics designed to enhance the body’s immune response to cancer. These conditionally activated proinflammatory immune modulators, called INDUKINE
Our Team Werewolf Therapeutics Inc.
Werewolf Therapeutics is backed by leading life science investors and led by an experienced team with a proven track record of developing novel medicines for the treatment of cancer. Dr. Dan Hicklin is an accomplished cancer researcher and biopharmaceutical executive with over three decades of oncology drug development experience.
Werewolf Therapeutics Overview, News & Competitors
Werewolf Therapeutics to Present at Upcoming Conferences in November 2021 CAMBRIDGE, Mass., Nov. 08, 2021 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (Nasdaq: HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to stimulate the body’s immune system for the treatment of cancer, ...
Werewolf Therapeutics Company Profile Office Locations
Werewolf Therapeutics has 28 employees at their 1 location. See insights on Werewolf Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
Werewolf Therapeutics, Inc. IPOScoop
(Note: Werewolf Therapeutics upsized its IPO at pricing on April 29, 2021, to 7.5 million shares, up from 6.25 million shares in the prospectus, at $16 – the mid-point of its $15-to-$17 range – to raise. Industry: PHARMACEUTICAL PREPARATIONS: Employees: 28: Founded: 2017: Contact Information: Address: 1030 Massachusetts Avenue, Suite 210
MPM Capital Powering Breakthroughs in Life Sciences
Werewolf Therapeutics Announces Pricing of Upsized Initial Public Offering. April 13, 2021. Pankaj Bhargava was a central figure in the group fashioning Gilead’s oncology strategy. Now he’s jumped to the VC side and the next-gen game at Dana-Farber. April 13, 2021
Our Science Werewolf Therapeutics Inc.
INDUKINE™ molecules are systemically administered in an inactive form and, upon entering the tumor microenvironment, are selectively activated to deliver the full biological potency of cytokines and recruit a powerful anti-tumor immune response. Therefore, INDUKINE™ molecules deliver maximum therapeutic potential while minimizing unwanted off-target effects in non-tumor ...
Werewolf Therapeutics Launches with $56M Series A
Werewolf Therapeutics is an oncology biotherapeutics company advancing a pipeline of next-generation, transformative cancer treatments designed to focus the body's immune response to selectively
Werewolf Therapeutics, Inc. (HOWL) Stock Price Today
Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts. More Sector Health Care Industry Biotechnology Employees 36 Founded 2017 Address 1030
Werewolf Therapeutics: Employee Directory ZoomInfo.com
Werewolf Therapeutics Employee Directory. Werewolf Therapeutics corporate office is located in 1030 Massachusetts Ave, Ste 210, Cambridge, Massachusetts, United States and has 30 employees. werewolf therapeutics, inc. werewolf therapeutics inc. werewolf therapeutics , inc. werewolf therapeutics. investors.werewolftx.com. werewolf therapeutics inc.
David Thompson Werewolf Therapeutics ZoomInfo.com
View David Thompson's business profile at Werewolf Therapeutics. Find contact's direct phone number, email address, work history, and more.
Howl Yahoo Search Results
Dec 27, 2021 · A high-level overview of Werewolf Therapeutics, Inc. (HOWL) stock.Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Werewolf Therapeutics MassBio
139 617.674 Massachusetts Biotechnology Council. 700 Technology Square, 5th Floor Cambridge, MA 02139 617.674.5100
Werewolf Therapeutics Crunchbase Company Profile & ...
Werewolf Therapeutics, Inc. is an innovative biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. We are leveraging our proprietary PREDATOR™ platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the